ALPS Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-27,512
| Closed | -$1.51M | – | 818 |
|
|
2019
Q3 | $1.51M | Sell |
27,512
-2,223
| -7% | -$122K | 0.01% | 242 |
|
|
2019
Q2 | $1.21M | Buy |
+29,735
| New | +$1.21M | 0.01% | 289 |
|
|
2018
Q1 | – | Sell |
-8,398
| Closed | -$453K | – | 871 |
|
|
2017
Q4 | $453K | Hold |
8,398
| – | – | ﹤0.01% | 639 |
|
|
2017
Q3 | $487K | Buy |
+8,398
| New | +$487K | ﹤0.01% | 572 |
|
|
2017
Q1 | – | Sell |
-8,849
| Closed | -$433K | – | 737 |
|
|
2016
Q4 | $433K | Sell |
8,849
-116
| -1% | -$5.68K | ﹤0.01% | 532 |
|
|
2016
Q3 | $429K | Buy |
+8,965
| New | +$429K | ﹤0.01% | 414 |
|
|
2016
Q1 | – | Sell |
-14,012
| Closed | -$535K | – | 639 |
|
|
2015
Q4 | $535K | Hold |
14,012
| – | – | 0.01% | 361 |
|
|
2015
Q3 | $4.46K | Buy |
14,012
+778
| +6% | +$248 | ﹤0.01% | 591 |
|
|
2015
Q2 | $437K | Buy |
13,234
+206
| +2% | +$6.8K | ﹤0.01% | 609 |
|
|
2015
Q1 | $536K | Buy |
13,028
+404
| +3% | +$16.6K | ﹤0.01% | 352 |
|
|
2014
Q4 | $514K | Sell |
12,624
-1,792
| -12% | -$73K | ﹤0.01% | 448 |
|
|
2014
Q3 | $528K | Buy |
14,416
+580
| +4% | +$21.2K | ﹤0.01% | 551 |
|
|
2014
Q2 | $641K | Buy |
13,836
+352
| +3% | +$16.3K | 0.01% | 294 |
|
|
2014
Q1 | $554K | Sell |
13,484
-6,922
| -34% | -$284K | 0.01% | 493 |
|
|
2013
Q4 | $679K | Buy |
20,406
+9,878
| +94% | +$329K | 0.01% | 161 |
|
|
2013
Q3 | $252K | Buy |
+10,528
| New | +$252K | ﹤0.01% | 377 |
|